Detalles de la búsqueda
1.
Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options.
G Ital Dermatol Venereol
; 150(1): 19-26, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25521808
2.
Treatment of psoriasis with different dosage regimens of etanercept: preliminary results from the Tαranta Plastic Study Group.
Int J Immunopathol Pharmacol
; 23(3): 797-802, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20943050
3.
A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite project.
Int J Immunopathol Pharmacol
; 22(1): 227-33, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19309570
4.
Efalizumab in moderate-to-severe plaque psoriasis: a retrospective case series analysis from clinical practice.
J Biol Regul Homeost Agents
; 22(3): 185-93, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18842172
5.
Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study).
Int J Immunopathol Pharmacol
; 19(1): 225-9, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16569361
6.
Safe use of efalizumab in a psoriasis patient with chronic heart failure due to hypertrophic cardiomyopathy.
G Ital Dermatol Venereol
; 143(2): 167, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18833044
7.
Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioning.
G Ital Dermatol Venereol
; 148(6 Suppl 1): 1-10, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24675369
Resultados
1 -
7
de 7
1
Próxima >
>>